Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. Dibenylene
2. Dibenyline
3. Dibenziran
4. Dibenzylin
5. Dibenzyline
6. Dibenzyran
7. Hydrochloride, Phenoxybenzamine
8. Phenoxybenzamine
1. 63-92-3
2. Phenoxybenzamine Hcl
3. Dibenzyline
4. N-benzyl-n-(2-chloroethyl)-1-phenoxypropan-2-amine Hydrochloride
5. Dibenzyline Hydrochloride
6. Dibenzyran
7. Dibenzyline Chloride
8. Phenoxybenzamine Chloride
9. Phenoxybenzamine (hydrochloride)
10. Bensylyt Nen
11. Dibenzylin
12. Phenoxybenzamine.hcl
13. Nci-c01661
14. Nsc-37448
15. 2-(n-benzyl-2-chloroethylamino)-1-phenoxypropane Hydrochloride
16. N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)benzylamine Hydrochloride
17. Mls000069374
18. Chebi:8078
19. Nsc 37448
20. 63-92-3 (hcl)
21. Smr000058422
22. N-benzyl-n-(2-chloroethyl)-1-phenoxypropan-2-amine;hydrochloride
23. Dsstox_cid_1127
24. N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)benzenemethanamine Hydrochloride
25. Benzenemethanamine, N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)-,hydrochloride
26. Dsstox_rid_75958
27. Dsstox_gsid_21127
28. N-2-phenoxyisopropyl-n-benzyl-chloroethylamine Hydrochloride
29. Benzyl(2-chloroethyl)(1-methyl-2-phenoxyethyl)amine Hydrochloride
30. X1ieg24ohl
31. Benzylamine, N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)-, Hydrochloride
32. Benzenemethanamine, N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)-, Hydrochloride
33. Phenoxybenzamine Hydrochloride (usp)
34. Sr-01000000017
35. Dibenzylene
36. Dibenzyline (tn)
37. Mfcd00055152
38. Pob Hcl
39. Cpd000058422
40. Opera_id_300
41. Cas-63-92-3
42. Phenoxybenzaminehydrochloride
43. Schembl50729
44. Bensylyte Hydrochloride
45. Mls002222313
46. Spectrum2300176
47. Chembl1200787
48. Dtxsid0021127
49. Hy-b0431a
50. Hms1570n10
51. Pharmakon1600-02300176
52. Phenoxybenzamine Hydrochloride,(s)
53. Bcp28467
54. Nsc37448
55. Tox21_201588
56. Tox21_302978
57. Wln: G2n1r&y1&1or &gh
58. Ccg-39614
59. Nsc759572
60. Akos015966790
61. Ac-8077
62. Lp00235
63. Nc00598
64. Nsc-759572
65. Ncgc00089748-02
66. Ncgc00089748-06
67. Ncgc00093699-01
68. Ncgc00093699-02
69. Ncgc00093699-03
70. Ncgc00093699-04
71. Ncgc00256370-01
72. Ncgc00259137-01
73. As-16927
74. Phenoxybenzamine Hydrochloride [mi]
75. Db-054579
76. B-019
77. D0158
78. Eu-0100235
79. Ft-0603264
80. Ft-0673569
81. Ft-0673570
82. N-benzyl-n-(2-chloroethyl)-1-phenoxypropan
83. Phenoxybenzamine Hydrochloride [iarc]
84. Phenoxybenzamine Hydrochloride [vandf]
85. S2499
86. Sw197327-3
87. En300-52514
88. Phenoxybenzamine Hydrochloride [mart.]
89. C07436
90. D00507
91. Phenoxybenzamine Hydrochloride [usp-rs]
92. Phenoxybenzamine Hydrochloride [who-dd]
93. Phenoxybenzamine Hydrochloride, >=97%, Powder
94. 055p152
95. J-009731
96. Phenoxybenzamine Hydrochloride [orange Book]
97. Sr-01000000017-2
98. Sr-01000000017-6
99. Phenoxybenzamine Hydrochloride [usp Monograph]
100. Q27107723
101. N-benzyl-n-(2-chloroethyl)-1-phenoxypropan-2-amine;hydron;chloride
102. N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)benzylamine, Hydrochloride
103. N-2-phenoxyisopropyl-n-benzyl-.beta.-chloroethylamine Hydrochloride
104. Benzenemethanamine, N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)-, Hydrochloride (1:1)
105. Benzenemethanamine, N-(2-chloroethyl)-n-(1-methyl-2-phenoxyethyl)-,hcl
106. Phenoxybenzamine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
107. 34238-85-2
108. Phenoxybenzamine Hcl Pound>>nci-c01661 Pound>> Nci C01661 Pound>> Ncic01661 Pound>>nsc 37448 Pound>>nsc37448 Pound>>nsc-37448
109. Phenoxybenzamine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 340.3 g/mol |
---|---|
Molecular Formula | C18H23Cl2NO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 8 |
Exact Mass | 339.1156697 g/mol |
Monoisotopic Mass | 339.1156697 g/mol |
Topological Polar Surface Area | 12.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 262 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Dibenzyline |
Drug Label | Each Dibenzyline capsule, with red cap and body, is imprinted WPC 001 and 10 mg, and contains 10 mg of Phenoxybenzamine Hydrochloride USP. Inactive ingredients consist of D&C Red No. 33, FD&C Red No. 3, FD&C Yellow No. 6, Gelatin NF, Lactose N |
Active Ingredient | Phenoxybenzamine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 10mg |
Market Status | Prescription |
Company | Wellspring Pharm |
2 of 4 | |
---|---|
Drug Name | Phenoxybenzamine hydrochloride |
PubMed Health | Phenoxybenzamine (By mouth) |
Drug Classes | Cardiovascular Agent |
Drug Label | Each Dibenzyline capsule, with red cap and body, is imprinted WPC 001 and 10 mg, and contains 10 mg of Phenoxybenzamine Hydrochloride USP. Inactive ingredients consist of D&C Red No. 33, FD&C Red No. 3, FD&C Yellow No. 6, Gelatin NF, Lactose N |
Active Ingredient | Phenoxybenzamine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 10mg |
Market Status | Prescription |
Company | Roxane |
3 of 4 | |
---|---|
Drug Name | Phenoxybenzamine hydrochloride |
PubMed Health | Phenoxybenzamine (By mouth) |
Drug Classes | Cardiovascular Agent |
Drug Label | Each Dibenzyline capsule, with red cap and body, is imprinted WPC 001 and 10 mg, and contains 10 mg of Phenoxybenzamine Hydrochloride USP. Inactive ingredients consist of D&C Red No. 33, FD&C Red No. 3, FD&C Yellow No. 6, Gelatin NF, Lactose N |
Active Ingredient | Phenoxybenzamine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 10mg |
Market Status | Prescription |
Company | Roxane |
4 of 4 | |
---|---|
Drug Name | Dibenzyline |
Drug Label | Each Dibenzyline capsule, with red cap and body, is imprinted WPC 001 and 10 mg, and contains 10 mg of Phenoxybenzamine Hydrochloride USP. Inactive ingredients consist of D&C Red No. 33, FD&C Red No. 3, FD&C Yellow No. 6, Gelatin NF, Lactose N |
Active Ingredient | Phenoxybenzamine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 10mg |
Market Status | Prescription |
Company | Wellspring Pharm |
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?